BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1558428)

  • 1. Current trends in the pharmacotherapy for gastroesophageal reflux disease.
    Hixson LJ; Kelley CL; Jones WN; Tuohy CD
    Arch Intern Med; 1992 Apr; 152(4):717-23. PubMed ID: 1558428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary medical therapy for gastroesophageal reflux disease.
    Fass R; Hixson LJ; Ciccolo ML; Gordon P; Hunter G; Rappaport W
    Am Fam Physician; 1997 Jan; 55(1):205-12, 217-8. PubMed ID: 9012279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease.
    Garnett WR
    Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical evaluation of proton pump inhibitors in the treatment of gastroesophageal reflux disease.
    Berardi RR
    Am J Manag Care; 2000 May; 6(9 Suppl):S491-505. PubMed ID: 10977489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment of gastroesophageal reflux disease.
    Ljubicić N; Habijanić E; Antić Z; Doko M; Kovacević I; Zovak M
    Acta Med Croatica; 1998; 52(2):133-8. PubMed ID: 9682502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic approaches to healing esophagitis.
    Boyce HW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends in the pharmacotherapy for peptic ulcer disease.
    Hixson LJ; Kelley CL; Jones WN; Tuohy CD
    Arch Intern Med; 1992 Apr; 152(4):726-32. PubMed ID: 1558429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe gastroesophageal reflux disease. Medical and surgical options for long-term care.
    Marshall JB
    Postgrad Med; 1995 May; 97(5):98-106. PubMed ID: 7753750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.
    Dobrilla G; Di Fede F
    Clin Ther; 1993; 15 Suppl B():2-13. PubMed ID: 7911400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of gastroesophageal reflux disease.
    Kaplan B; Koppelo KL
    W V Med J; 1994 Dec; 90(12):510-7. PubMed ID: 7863640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and treatment of gastroesophageal reflux disease.
    Ogorek CP; Fisher RS
    Gastroenterol Clin North Am; 1989 Jun; 18(2):293-313. PubMed ID: 2668171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroesophageal reflux: clinical diagnosis, current therapy, future trends.
    Decktor DL; Robinson MG
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():11-7. PubMed ID: 1976582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.